MiR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1473-1479

  Zhang, Han Han ^a   Pang, Min ^a   Dong, Wei ^b,c   Xin, Jia Xuan ^a   Li, You Jie ^a   Zhang, Zi Cheng ^b   Yu, Liang ^a   Wang, Ping Yu ^a   Li, Bao Sheng ^c   Xie, Shu Yang ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

BAX; Lung adenocarcinoma; MiR 511; Radioresistance; TRIB2

Indexed keywords

MICRORNA; MICRORNA 511; PROTEIN BAX; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; TRIB2 GENE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICRORNAS; RADIATION TOLERANCE; RNA INTERFERENCE;

EID: 84896738753     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.2973     Document Type: Article

References (35)

1. Mokdad AH, Marks JS, Stroup DF and Gerberding JL: Actual causes of death in the United States, 2000. JAMA 291: 1238-1245, 2004. (Pubitemid 38541668)
2. Centers for Disease Control and Prevention: Tobacco use among adults - United States, 2005. MMWR Morb Mortal Wkly Rep 55: 1145-1148, 2006.
3. Tyldesley S, Boyd C, Schulze K, Walker H and Mackillop WJ: Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys 49: 973-985, 2001. (Pubitemid 32184604)
4. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr and Green MR: Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88: 1210-1215, 1996. (Pubitemid 26302034)
5. Bradley JD, Paulus R, Graham MV, et al: Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group - RTOG 9705. J Clin Oncol 23: 3480-3487, 2005.
6. Biard DS, Martin M, Rhun YL, et al: Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54: 3361-3364, 1994. (Pubitemid 24225948)
7. Wang H, Yu JM, Yang GR, et al: Further characterization of the epidermal growth factor receptor ligand 11C-PD153035. Chin Med J 120: 960-964, 2007. (Pubitemid 46902174)
8. Xu QY, Gao Y, Liu Y, Yang WZ and Xu XY: Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J 121: 1830-1837, 2008.
9. Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE and Leder P: atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 16: 397-401, 1997. (Pubitemid 27323309)
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Calin GA and Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394, 2006. (Pubitemid 44289189)
12. Calin GA, Garzon R, Cimmino A, Fabbri M and Croce CM: MicroRNAs and leukemias: how strong is the connection? Leuk Res 30: 653-655, 2006.
13. Hammond SM: MicroRNAs as oncogenes. Curr Opin Genet Dev 16: 4-9, 2006.
14. Weidhaas JB, Babar I, Nallur SM, et al: MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111-11116, 2007. (Pubitemid 350248533)
15. Jeong SH, Wu HG and Park WY: LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 41: 912-918, 2009.
16. Zhang C, Chi YL, Wang PY, et al: miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. PLoS One 7: e46090, 2012.
17. Li YJ, Zhang YX, Wang PY, et al: Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol Rep 27: 129-134, 2012.
18. Yan L, Xu G, Qiao T, Chen W, Yuan S and Li X: CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9. Cancer Biother Radiopharm 28: 559-564, 2013.
19. Wang PY, Sun YX, Zhang S, et al: Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett 587: 2675-2681, 2013.
20. Kiss-Toth E, Bagstaff SM, Sung HY, et al: Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 279: 42703-42708, 2004. (Pubitemid 39372156)
21. Lee JH, Lee SW, Choi SH, Kim SH, Kim WJ and Jung JY: p38 MAP kinase and ERK play an important role in nitric oxide-induced apoptosis of the mouse embryonic stem cells. Toxicol In Vitro 27: 492-498, 2013.
22. Ogawa K, Utsunomiya T, Mimori K, et al: Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 28: 705-713, 2006.
23. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
24. Lanza G, Ferracin M, Gafà R, et al: mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54, 2007.
25. Chung WM, Chang WC, Chen L, et al: MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro. Stem Cell Res Ther 4: 88, 2013.
26. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77: 12-21, 2009.
27. Tarasov V, Jung P, Verdoodt B, et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593, 2007. (Pubitemid 47327945)
28. Chao TF, Xiong HH, Liu W, Chen Y and Zhang JX: MiR-21 mediates the radiation resistance of glioblastoma cells by regulating PDCD4 and hMSH2. J Huazhong Univ Sci Technolog Med Sci 33: 525-529, 2013.
29. Shi Y, Zhang X, Tang X, Wang P, Wang H and Wang Y: MiR-21 is continually elevated long-term in the brain after exposure to ionizing radiation. Radiat Res 177: 124-128, 2012.
30. Saleh AD, Savage JE, Cao L, et al: Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One 6: e24429, 2011.
31. Hannon MM, Lohan F, Erbilgin Y, et al: Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL. Br J Haematol 158: 626-634, 2012.
32. Wang J, Park JS, Wei Y, et al: TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function. Mol Cell 51: 211-225, 2013.
33. Wei SC, Rosenberg IM, Cao Z, Huett AS, Xavier RJ and Podolsky DK: Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling. Inflamm Bowel Dis 18: 877-888, 2012.
34. Csuka O, Remenár E, Koronczay K, Doleschall Z and Németh G: Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer. Pathol Oncol Res 3: 204-210, 1997.
35. Kim KW, Mutter RW, Cao C, et al: Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 281: 36883-36890, 2006. (Pubitemid 46042156)